Frequency of Erectile Dysfunction in Patients with Type 2 Diabetes Mellitus Presenting with Peripheral Neuropathy at a Tertiary Care Hospital

Main Article Content

Sarmad Ali
Musarrat Riaz
Abdul Basit

Abstract

Background: Erectile dysfunction (ED) is notably prevalent among patients with type 2 diabetes mellitus (T2DM), especially those suffering from peripheral neuropathy. The condition significantly impacts the quality of life and is often exacerbated by diabetes-related complications.


Objective: This study aims to ascertain the frequency and severity of ED among patients with T2DM and peripheral neuropathy, and to examine the association between ED and variables such as age, duration of diabetes, and glycemic control.


Methods: A prospective cohort study was conducted at the Baqai Institute of Diabetology and Endocrinology, Karachi, from July 2021 to September 2022. We included 115 male patients aged 35-65 years with T2DM and diagnosed peripheral neuropathy. ED was assessed using the Urdu version of the International Index of Erectile Function-5 (IIEF-5) questionnaire. Demographic details, medical history, and laboratory results were collected and analyzed using SPSS version 25. Statistical tests included chi-squared and one-way ANOVA, with a significance level set at p<0.05.


Results: The mean age of the participants was 50.97 ± 7.21 years, and the average duration of diabetes was 9.37 ± 6.56 years. The mean IIEF-5 score was 14.33 ± 6.0, indicating moderate ED. Severe ED was observed in 20% of the participants, moderate ED in 19.1%, and mild to moderate ED in 28.7%. The study found a significant association between the duration of diabetes and ED severity (p < 0.001), while age and HbA1c levels did not show a significant correlation with ED status.


Conclusion: ED is highly prevalent and severe among patients with T2DM and peripheral neuropathy, with disease duration being a significant predictor of ED severity. These findings underscore the need for early screening and targeted interventions in this population.

Article Details

How to Cite
Ali , S., Riaz , M., & Basit, A. (2024). Frequency of Erectile Dysfunction in Patients with Type 2 Diabetes Mellitus Presenting with Peripheral Neuropathy at a Tertiary Care Hospital. Journal of Health and Rehabilitation Research, 4(2), 487–491. https://doi.org/10.61919/jhrr.v4i2.778
Section
Articles
Author Biographies

Sarmad Ali , Baqai Medical University Karachi Pakistan.

FCPS, Endocrine Fellow, Baqai Institute of Diabetology and Endocrinology, Baqai Medical University, Karachi-Pakistan.

Musarrat Riaz , Baqai Medical University Karachi Pakistan.

FCPS, Associate Professor, Department of Medicine, Consultant Endocrinologist, Baqai Institute of Diabetology and Endocrinology, Baqai Medical University, Karachi-Pakistan.

Abdul Basit, Baqai Medical University Karachi Pakistan.

FRCP, Professor of Medicine, Baqai Institute of Diabetology and Endocrinology, Baqai Medical University, Karachi-Pakistan.

References

Malavige LS, Levy JC. Erectile Dysfunction in Diabetes Mellitus. J Sex Med. 2009 May;6(5):1232-47. doi: 10.1111/j.1743-6109.2008.01168.x.

Furukawa S, Sakai T, Niiya T, Miyaoka H, Miyake T, Yamamoto S, et al. Diabetic Peripheral Neuropathy and Prevalence of Erectile Dysfunction in Japanese Patients Aged < 65 Years with Type 2 Diabetes Mellitus: The Dogo Study. Int J Impot Res. 2017 Jan;29(1):30-4. doi: 10.1038/ijir.2016.40.

Binmoammar TA, Hassounah S, Alsaad S, Rawaf S, Majeed A. The Impact of Poor Glycaemic Control on the Prevalence of Erectile Dysfunction in Men with Type 2 Diabetes Mellitus: A Systematic Review. JRSM Open. 2016 Feb 12;7(3):2054270415622602. doi: 10.1177/2054270415622602.

Sun J, Wang Y, Zhang X, Zhu S, He H. Prevalence of Peripheral Neuropathy in Patients with Diabetes: A Systematic Review and Meta-Analysis. Prim Care Diabetes. 2020 Oct 1;14(5):435-44. doi: 10.1016/j.pcd.2019.12.005.

Kouidrat Y, Pizzol D, Cosco T, Thompson T, Carnaghi M, Bertoldo A, et al. High Prevalence of Erectile Dysfunction in Diabetes: A Systematic Review and Meta-Analysis of 145 Studies. Diabet Med. 2017 Sep;34(9):1185-92. doi: 10.1111/dme.13403.

Defeudis G, Gianfrilli D, Di Emidio C, Pofi R, Tuccinardi D, Palermo A, et al. Erectile Dysfunction and Its Management in Patients with Diabetes Mellitus. Rev Endocr Metab Disord. 2015 Sep;16:213-31. doi: 10.1007/s11154-015-9321-4.

Løseth S, Stålberg EV, Lindal S, Olsen E, Jorde R, Mellgren SI. Small and Large Fiber Neuropathy in Those with Type 1 and Type 2 Diabetes: A 5-Year Follow-Up Study. J Peripher Nerv Syst. 2016 Mar;21(1):15-21. doi: 10.1111/jns.12154.

Raheem OA, Su JJ, Wilson JR, Hsieh TC. The Association of Erectile Dysfunction and Cardiovascular Disease: A Systematic Critical Review. Am J Men's Health. 2017 May;11(3):552-63. doi: 10.1177/1557988316630305.

Maffei L, Premrou V, Roldan P, Copetti M, Pellegrini F, Rossi MC, et al. Vibration Perception Threshold in the Screening of Sensorimotor Distal Symmetric Polyneuropathy: The Need of More Accurate Age-Specific Reference Values. J Diabetes Sci Technol. 2014 May;8(3):621-2. doi: 10.1177/1932296814527818.

Defeudis G, Mazzilli R, Tenuta M, Rossini G, Zamponi V, Olana S, et al. Erectile Dysfunction and Diabetes: A Melting Pot of Circumstances and Treatments. Diabetes Metab Res Rev. 2022 Feb;38(2):e3494. doi: 10.1002/dmrr.3494.

Singh P, Arora S, Goyal A, Mittal N, Singh A, Sharma S, et al. Influence of the Duration of Diabetes and Vibration Perception Threshold on the Severity of Erectile Dysfunction in Patients with Type 2 Diabetes Mellitus. Acta Endocrinol (Buch). 2022 Apr;18(2):174. doi: 10.4183/aeb.2022.174.

Sasaki H, Yamasaki H, Ogawa K, Nanjo K, Kawamori R, Iwamoto Y, et al. Prevalence and Risk Factors for Erectile Dysfunction in Japanese Diabetics. Diabetes Res Clin Pract. 2005 Oct 1;70(1):81-9. doi: 10.1016/j.diabres.2005.02.018.

Mahmood MA, Rehman KU, Khan MA, Sultan T. Translation, Cross-Cultural Adaptation, and Psychometric Validation of the 5-Item International Index of Erectile Function (IIEF-5) into Urdu. J Sex Med. 2012 Jul;9(7):1883-6. doi: 10.1111/j.1743-6109.2012.02714.x.

Himeno T, Kamiya H, Nakamura J. Lumos for the Long Trail: Strategies for Clinical Diagnosis and Severity Staging for Diabetic Polyneuropathy and Future Directions. J Diabetes Investig. 2020 Jan;11(1):5-16. doi: 10.1111/jdi.13173.

Medakkel AA, Sheela P. Vibration Perception Threshold Values and Clinical Symptoms of Diabetic Peripheral Neuropathy. J Clin Diagn Res. 2018 May 1;12(5). doi: 10.7860/JCDR/2018/32825.11549.

Goyal A, Singh P, Ahuja A. Prevalence and Severity of Erectile Dysfunction as Assessed by IIEF-5 in North Indian Type 2 Diabetic Males and Its Correlation with Variables. J Clin Diagn Res. 2013 Dec;7(12):2936. doi: 10.7860/JCDR/2013/7718.3777.

Defeudis G, Di Tommaso AM, Di Rosa C, Cimadomo D, Khazrai YM, Faggiano A, et al. The Role of Antihyperglycemic Drugs and Diet on Erectile Function: Results from a Perspective Study on a Population with Prediabetes and Diabetes. J Clin Med. 2022 Jun 13;11(12):3382. doi: 10.3390/jcm11123382.

Ghanem YM, Zahran AR, Younan DN, Zeitoun MH, El Feky AY. Prevalence of Erectile Dysfunction Among Egyptian Male Patients with Type 2 Diabetes Mellitus. Diabetes Metab Syndr Clin Res Rev. 2021 May 1;15(3):949-53. doi: 10.1016/j.dsx.2021.04.019.

Gandaglia G, Briganti A, Jackson G, Kloner RA, Montorsi F, Montorsi P, et al. A Systematic Review of the Association Between Erectile Dysfunction and Cardiovascular Disease. Eur Urol. 2014 May 1;65(5):968-78. doi: 10.1016/j.eururo.2013.08.023.

Hameed A, Ahmad M, Shaikh S, Abid A. Prevalence of erectile dysfunction among Type-2 diabetes mellitus and availability of treatment options in Pakistan. International Journal of Diabetes & Metabolic Disorders. 2023 Jun 14;8(2):351-4.